Salbutamol Sulfate Ph. Eur.

2 trials RRespiratory

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

9 Countries

Phase III

Phase III: 2

Oversight events:

1 urgent safety measure 1 corrective measure across 1 trial

View oversight register →

Sponsors using this IMP

Areteia Therapeutics Inc. 2

All trials

2 total

A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) Not authorised

2023-503693-20-00 Phase III 1 country Areteia Therapeutics Inc.
A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) Ended

2023-503693-20-01 Phase III 9 countries Areteia Therapeutics Inc.

Showing 1–2 of 2 trials

← All drugs A–Z